Luwei Pharmaceutical's VC derivatives project
Summary: On 30 June, Luwei Pharmaceutical made a public announcement on its project of 40,000 t/a sodium ascorbate and calcium ascorbate as well as 30,000 t/a L-ascorbate-2-phosphate.On 30 June, Shandong Luwei Pharmaceutical Co., Ltd. (Luwei Pharmace...
Vitamins China E-News 202007